Madrigal Pharmaceuticals beat Q1 sales estimates with Rezdiffra, and catalysts like EU approval and pipeline plans add upside ...

On a quest to expand the eligible patient pool for its fast-growing liver disease drug Rezdiffra, Madrigal Pharmaceuticals ...

The magical world of the Disney Lorcana embraces the Reign of Jafar as Set 8 hits card shops this month from Ravensburger ...

Duffy is the second member of Trump’s cabinet who sold securities shortly before the president’s tariff announcements sent ...

On May 17, hundreds of people gathered to celebrate the strength and diversity of the disability community at the second ...

Madrigal Pharmaceuticals has a first mover advantage in the huge MASH market due to the approval of Rezdiffra. Read whether I ...

Durango city councilors quietly met with La Plata County commissioners for a “meet-and-greet” – with no staff present – at ...

CONSHOHOCKEN, PA — Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) has announced two-year results from the open-label arm of ...

The Lion King fans can save big on Lego's large-scale model kit of Young Simba for a limited time. The 1,445-piece Lego ...

We recently published a list of Billionaire John Paulson’s 10 Stocks with Huge Upside Potential. In this article, we are ...

Calvo and Ambrossi, who are known jointly as Los Javis and made waves with genre-bending thriller La Mesias, unveiled fresh ...

Madrigal Pharmaceuticals announced positive results from the Phase 3 MAESTRO-NAFLD-1 trial of their drug Rezdiffra, focusing on patients with compensated metabolic dysfunction-associated ...